US Patent 11629164 Gemcitabine prodrugs
Patent 11629164 was granted and assigned to NuCana on April, 2023 by the United States Patent and Trademark Office.
All edits
Edits on 14 Aug, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Christopher McGuigan0
Hugh Griffith0
Magdalena Slusarczyk0
Michaela Serpi0
Valentina Ferrari0
Edits on 22 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 19 Apr, 2023
Golden AI
Edits made to:
Infobox (+15 properties)
Article (+169 characters)
US Patent 11629164 Gemcitabine prodrugs
Article
This invention relates to a prodrug of the monophosphate nucleotide of the well-known oncology drug gemcitabine. Specifically, it relates to gemcitabine-[phenyl-benzoxy-
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
116291640
Date of Patent
April 18, 2023
0Patent Application Number
168655270
Date Filed
May 4, 2020
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11629164 Gemcitabine prodrugs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
